Victory Capital Holdings, Inc. (NASDAQ: VCTR) ("Victory Capital" or the "Company") today published an open letter from ...
AbbVie (NYSE: ABBV) today announced positive topline results from the Phase 3, randomized, placebo-controlled, double-blind AFFIRM study evaluating the efficacy and safety of risankizumab (SKYRIZI®) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results